ad

4726 永昕生物醫藥

本益成長比: 10.425  總報酬本益比: 0.096  合理價格(本益比法): N/A  合理價格(ROE法): N/A
永昕生物醫藥
  • EPS 年複合成長率: 16.71% (109-105)
  • 營業利益年複合成長率: 16.66% (109-105)
  • 本益比: 173.68
  • 近四季EPS總合: 0.19 (-0.45,0.85,-0.1,-0.11)
  • 融資餘額佔股本比例:N/A
  • 融資使用率: N/A
  • 近期收盤價: 33.0 (2021-10-22)

營業毛利率,營業利益率,稅前淨利率,股東權益報酬率-近5年

20202019201820172016
營業毛利率28.0433.906.6743.8820.06
營業利益率5.32-58.91-152.55-38.12-108.87
折舊負擔比率18.2027.8836.9719.4420.40
稅前淨利率4.20-58.84-135.17-64.56-78.83
股東權益報酬率2.68-21.72-26.76-15.31-11.44
資產報酬率2.00-17.15-22.55-13.94-10.90
本業收入比125.00100.00112.9458.74137.97
業外獲益比-25.00-0.00-12.9440.78-37.97
無形資產佔淨值比3.485.331.160.000.00




營業毛利率,營業利益率,稅前淨利率,股東權益報酬率-近8季

2021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q3
營業毛利率-24.4056.8117.5412.4047.9411.3737.3113.66
營業利益率-60.5939.24-3.90-9.3730.55-37.11-30.20-123.46
折舊負擔比率32.7111.6419.1020.9510.4140.0021.3734.62
稅前淨利率-64.7239.44-6.35-10.9328.84-31.61-33.86-125.15
股東權益報酬率-3.356.91-1.01-1.116.90-2.01-3.81-7.79
資產報酬率-2.685.28-0.78-0.865.35-1.48-2.95-5.99
本業收入比94.20100.0063.6487.50105.13118.1888.8997.96
業外獲益比5.800.8736.3612.50-6.41-18.1811.111.02
無形資產佔淨值比2.312.203.483.954.454.875.335.40




現金流量-近5年 (1.避開近3年累計小於0的公司 2.營運現金流量要大於稅後淨利,除非受到應收帳款和存貨影響 3.營運現金流量不應該都是流出)

20202019201820172016
營運現金流量(百萬)174-141-180-46-158
自由現金流量(百萬)5-407-12630-2
稅後淨利(百萬)31-218-274-188-158




現金流量-近8季

2021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q3
營運現金流量(百萬)-703951205053-8429
自由現金流量(百萬)-272-52-20-923087-77-66
稅後淨利(百萬)-69114-12-1479-22-43-93




成長能力-近5年 (營業利益和稅後淨利成長率要大於營業收入成長率)

20202019201820172016
營業收入(百萬)665391211319201
營業利益(百萬)35-230-323-121-218
稅後淨利(百萬)31-218-274-188-158
EPS(完全稀釋)0.24-1.74-2.50-1.71-1.45
營業收入成長率(%)70.0885.31-33.8658.7148.89
營業利益成長率(%)115.2228.79-166.9444.50-54.61
稅後淨利成長率(%)114.2220.44-45.74-18.99-42.34
EPS成長率(%)113.7930.40-46.20-17.93-43.56




成長能力-近4季

2021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q3
營業收入(百萬)1072921781482697013178
營業利益(百萬)-65115-7-1482-26-40-96
稅後淨利(百萬)-69114-12-1479-22-43-93
EPS(完全稀釋)-0.450.85-0.10-0.110.62-0.17-0.34-0.73
去年同期營業收入成長率(%)-60.22317.1435.8889.74----
去年同期營業利益成長率(%)-179.27542.3182.5085.42----
去年同期稅後淨利成長率(%)-187.34618.1872.0984.95----
去年同期EPS成長率(%)-172.58600.0070.5984.93----
較上季營業收入成長率(%)-63.3664.0420.27-44.98284.29-46.5667.95-
較上季營業利益成長率(%)-156.521742.8650.00-117.07415.3835.0058.33-
較上季稅後淨利成長率(%)-160.531050.0014.29-117.72459.0948.8453.76-
較上季EPS成長率(%)-152.94950.009.09-117.74464.7150.0053.42-




每月營收變化

年/月月增率(%)去年同期年增率(%)累計營收年增率(%)
2021/971.0319.7913.59
2021/8109.06-8.5812.57
2021/74.61-11.5415.64
2021/6-57.01-86.917.74
2021/555.738.93122.06
2021/4-58.8-37.03165.76

稅前淨利較去年同期

2021Q2(百萬)2020Q2(百萬)YoY(%)
-69.078.0-188.4
2021Q1(百萬)2020Q1(百萬)YoY(%)
115.0-22.0622.72
2020Q4(百萬)2019Q4(百萬)YoY(%)
-11.0-45.075.555

EPS較上季

2021Q2(元)2021Q1(元)比率
-0.450.85-1.529

應收帳周轉率和存貨周轉率-近5年

20202019201820172016
應收帳款周轉率7.785.063.535.466.04
存貨周轉率6.794.433.703.704.39




應收帳周轉率和存貨周轉率-近8季

2021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q3
應收帳款周轉率1.403.692.332.065.330.951.831.15
存貨周轉率0.911.151.781.742.181.081.311.05




償債能力-近5年

20202019201820172016
負債比0.310.220.190.130.05
金融負債(百萬)1373729380
營業收入淨額(百萬)665391211319201
利息保障倍數33.33-118.72-964.510.000.00
長期銀行借款占稅後淨利比0.000.000.000.000.00




償債能力-近8季

2021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q3
負債比0.200.190.310.230.180.280.220.22
金融負債(百萬)383713737371373729
營業收入淨額(百萬)1072921781482697013178
利息保障倍數-295.45242.6315.62-34.71125.73-38.23-102.54-197.97
長期銀行借款占稅後淨利比0.000.000.000.000.000.000.000.00




成本指標-近5年

20202019201820172016
營業收入淨額(百萬)665391211319201
推銷費用(百萬)4536212510
管理費用(百萬)4941374131
研究發展費(百萬)47285276195218
推銷費用率(%)6.779.219.957.844.98
管理費用率(%)7.3710.4917.5412.8515.42
研究發展費用率(%)7.0772.89130.8161.13108.46




成本指標-近8季

2021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q3
營業收入淨額(百萬)1072921781482697013178
推銷費用(百萬)810912159126
管理費用(百萬)1518131215101013
研究發展費(百萬)18219814156787
推銷費用率(%)7.483.425.068.115.5812.869.167.69
管理費用率(%)14.026.167.308.115.5814.297.6316.67
研究發展費用率(%)16.827.195.065.415.2021.4351.15111.54




財務健檢燈號

上市滿三年資本額10億以上股本形成中現金增資比率低於50%負債比率低於50%董監持股設質低於10%現金(含約當現金)占股本超過50%過去4季累積正營運現金流量過去4季ROE超過25%過去6個月的營收維持正的年成長率過去4季的EPS年增率是正數
OOXOOXOXXX
8年15.33億96.69%20.38%0.0%40.12%40百萬-13.4%

融資使用率

日期股價融資使用率
2021-10-2233.0None%
2021-10-2133.4None%
2021-10-2033.55None%
2021-10-1933.7None%
2021-10-1833.3None%
2021-10-1533.25None%
2021-10-1433.4None%
2021-10-1332.2None%
2021-10-1232.5None%
2021-10-0834.05None%
2021-10-0734.3None%
2021-10-0633.7None%
2021-10-0534.2None%
2021-10-0433.85None%
2021-10-0137.5None%
2021-09-3038.6None%
2021-09-2937.85None%
2021-09-2839.15None%
2021-09-2739.55None%
2021-09-2439.8None%
2021-09-2339.6None%
2021-09-2239.05None%
2021-09-1739.8None%
2021-09-1640.7None%
2021-09-1540.9None%
2021-09-1441.25None%
2021-09-1341.45None%
2021-09-1041.75None%
2021-09-0942.4None%
2021-09-0841.4None%
2021-09-0742.3None%
2021-09-0641.0None%
2021-09-0341.45None%
2021-09-0240.7None%
2021-09-0140.7None%
2021-08-3141.05None%
2021-08-3041.0None%
2021-08-2741.2None%
2021-08-2641.25None%
2021-08-2541.0None%
2021-08-2440.9None%
2021-08-2341.5None%
2021-08-2041.15None%
2021-08-1940.65None%
2021-08-1841.25None%
2021-08-1740.6None%
2021-08-1640.75None%
2021-08-1341.2None%
2021-08-1241.2None%
2021-08-1140.8None%
2021-08-1041.95None%
2021-08-0942.3None%
2021-08-0643.7None%
2021-08-0543.4None%
2021-08-0443.5None%
2021-08-0344.35None%
2021-08-0246.2None%
2021-07-3044.5None%
2021-07-2943.25None%
2021-07-2841.15None%
2021-07-2741.1None%
2021-07-2642.5None%
2021-07-2341.3None%
2021-07-2240.95None%
2021-07-2141.35None%
2021-07-2042.25None%
2021-07-1941.7None%
2021-07-1641.4None%
2021-07-1541.1None%
2021-07-1440.65None%
2021-07-1341.25None%
2021-07-1244.0None%
2021-07-0941.0None%
2021-07-0841.3None%
2021-07-0740.35None%
2021-07-0640.55None%
2021-07-0541.2None%
2021-07-0241.8None%
2021-07-0142.2None%
2021-06-3042.85None%
2021-06-2941.2None%
2021-06-2840.8None%
2021-06-2541.85None%
2021-06-2441.7None%
2021-06-2342.1None%
2021-06-2242.0None%
2021-06-2142.8None%
2021-06-1842.75None%
2021-06-1741.75None%
2021-06-1641.55None%



沒有留言:

張貼留言